Bajaj Healthcare Share Price
330.55+0.00 (+0.67%)
-21.98% past 1 Year
Corporate filings & documents
Announcements
Intimation of Record Date for the payment of Final Dividend for the financial year 2025-26
2 weeks agoIntimation of Record Date for the payment of Final Dividend for the financial year 2025-26
2 weeks agoIntimation for newspaper publication- Dispatch of Notice of 33rd Annual General Meeting and Annual Report for the financial year 2025-26
3 weeks agoIntimation for newspaper publication- Dispatch of Notice of 33rd Annual General Meeting and Annual Report for the financial year 2025-26
3 weeks agoIntimation for Inland Letters sent to Shareholders
3 weeks agoIntimation for Inland Letters sent to Shareholders
3 weeks agoIntimation for Business Responsibility and Sustainability Report for the financial year 2025-26
3 weeks agoIntimation for Business Responsibility and Sustainability Report for the financial year 2025-26
3 weeks agoIntimation of the Annual Report for the financial year 2025-26
3 weeks agoIntimation of the Annual Report for the financial year 2025-26
3 weeks agoIntimation of 33rd Annual General Meeting and dispatch of Annual Report of the Company for the financial year 2025-26
3 weeks agoIntimation of 33rd Annual General Meeting and dispatch of Annual Report of the Company for the financial year 2025-26
3 weeks agoIntimation for Newspaper Publication with respect to 33rd Annual General Meeting of the Company
3 weeks agoIntimation for Newspaper Publication with respect to 33rd Annual General Meeting of the Company
3 weeks agoIntimation of allotment of equity shares pursuant to exercise of ESOPs
1 month agoIntimation of allotment of equity shares pursuant to exercise of ESOPs
1 month agoThe Company has received the approval from DCGI to manufacture and market Cenobamate API and Tablets
1 month agoThe Company has received the approval from DCGI to manufacture and market Cenobamate API and Tablets
1 month agoRevision in Credit Rating
1 month agoRevision in Credit Rating
1 month agoTranscript of Earnings Call for Q1FY27
1 month agoTranscript of Earnings Call for Q1FY27
1 month agoIntimation for Newspaper Publication
2 months agoIntimation for Newspaper Publication
2 months agoIntimation for Audio Recording of Earnings Call for Q1FY27
2 months agoIntimation for Audio Recording of Earnings Call for Q1FY27
2 months agoIntimation for Grant of Employee Stock Options under Bajaj Healthcare Limited Employee Stock Option Plan 2024
2 months agoIntimation for Grant of Employee Stock Options under Bajaj Healthcare Limited Employee Stock Option Plan 2024
2 months agoPress Release for the quarter ended June 30 2026
2 months agoPress Release for the quarter ended June 30 2026
2 months agoStatement of Deviation & Variation for the quarter ended June 30 2026
2 months agoStatement of Deviation & Variation for the quarter ended June 30 2026
2 months agoMonitoring Agency Report for the quarter ended June 30 2026
2 months agoMonitoring Agency Report for the quarter ended June 30 2026
2 months agoContinuation of directorship of Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director of the Company upon attaining the age of 75 years
2 months agoContinuation of directorship of Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director of the Company upon attaining the age of 75 years
2 months agoFinancial Results for the quarter ended June 30 2026
2 months agoFinancial Results for the quarter ended June 30 2026
2 months agoOutcome of the Board Meeting held on July 20 2026
2 months agoOutcome of the Board Meeting held on July 20 2026
2 months agoEarnings Call Invite
2 months agoEarnings Call Invite
2 months agoEarnings Call Invite
2 months agoEarnings Call Invite
2 months agoBajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2026 inter alia to consider and approve the Un-audited Financial Results for the quarter ended 30th June 2026
2 months agoBajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2026 inter alia to consider and approve the Un-audited Financial Results for the quarter ended 30th June 2026
2 months agoCompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
2 months agoCompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026
2 months agoThe Company has received a recommendation from SEC-CDSCO to manufacture and market Cenobamate Tablets
2 months agoThe Company has received a recommendation from SEC-CDSCO to manufacture and market Cenobamate Tablets
2 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
Oct 2025
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation